These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19052781)

  • 21. Importance of platinum(II)-assisted platinum(IV) substitution for the oxidation of guanosine derivatives by platinum(IV) complexes.
    Choi S; Vastag L; Larrabee YC; Personick ML; Schaberg KB; Fowler BJ; Sandwick RK; Rawji G
    Inorg Chem; 2008 Feb; 47(4):1352-60. PubMed ID: 18220340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Side-on binding of p-sulphonatocalix[4]arene to the dinuclear platinum complex trans-[{PtCl(NH3)2}2mu-dpzm]2+ and its implications for anticancer drug delivery.
    Wheate NJ; Abbott GM; Tate RJ; Clements CJ; Edrada-Ebel R; Johnston BF
    J Inorg Biochem; 2009 Mar; 103(3):448-54. PubMed ID: 19171382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amide-based prodrugs of spermidine-bridged dinuclear platinum. Synthesis, DNA binding, and biological activity.
    Hegmans A; Kasparkova J; Vrana O; Kelland LR; Brabec V; Farrell NP
    J Med Chem; 2008 Apr; 51(7):2254-60. PubMed ID: 18338842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel approaches to polynuclear platinum pro-drugs. Selective release of cytotoxic platinum-spermidine species through hydrolytic cleavage of carbamates.
    Hegmans A; Qu Y; Kelland LR; Roberts JD; Farrell N
    Inorg Chem; 2001 Nov; 40(24):6108-14. PubMed ID: 11703107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Possible biotransformation reactions of polynuclear Pt(II) complexes.
    Summa N; Maigut J; Puchta R; van Eldik R
    Inorg Chem; 2007 Mar; 46(6):2094-104. PubMed ID: 17311374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platinum(II) compounds with chelating ligands based on pyridine and pyrimidine: synthesis, characterizations, DFT calculations, cytotoxic assays and binding to a DNA model base.
    Roy S; Westmaas JA; Buda F; Reedijk J
    J Inorg Biochem; 2009 Sep; 103(9):1278-87. PubMed ID: 19656572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel isomerization on interaction of antitumor-active azole-bridged dinuclear platinum(II) complexes with 9-ethylguanine. Platinum(II) atom migration from N2 to N3 on 1,2,3-triazole.
    Komeda S; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J
    J Am Chem Soc; 2002 May; 124(17):4738-46. PubMed ID: 11971723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monofunctional platinum amine complexes destabilize DNA significantly.
    Bauer C; Peleg-Shulman T; Gibson D; Wang AH
    Eur J Biochem; 1998 Sep; 256(2):253-60. PubMed ID: 9760162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trans-platinum complexes in cancer therapy.
    Coluccia M; Natile G
    Anticancer Agents Med Chem; 2007 Jan; 7(1):111-23. PubMed ID: 17266508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The new antitumor compound, cis-[Pt(NH3)2(4-methylpyridine)Cl]Cl, does not form N7,N7-d(GpG) chelates with DNA. An unexpected preference for platinum binding at the 5'G in d(GpG).
    Lempers EL; Bloemink MJ; Brouwer J; Kidani Y; Reedijk J
    J Inorg Biochem; 1990 Sep; 40(1):23-35. PubMed ID: 2283508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platinum complexes with NH groups on the carrier ligand and with only one guanine or hypoxanthine derivative. Informative models for assessing relative nucleobase and nucleotide hydrogen-bond interactions with amine ligands in solution.
    Carlone M; Marzilli LG; Natile G
    Inorg Chem; 2004 Jan; 43(2):584-92. PubMed ID: 14731020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and X-ray crystal structure of trans,cis-[Pt(OAc)2I2(en)]: a novel type of cisplatin analog that can be photolyzed by visible light to DNA-binding and cytotoxic species in vitro.
    Kratochwil NA; Zabel M; Range KJ; Bednarski PJ
    J Med Chem; 1996 Jun; 39(13):2499-507. PubMed ID: 8691447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, X-ray crystallographic, and NMR characterizations of platinum(II) and platinum(IV) pyrophosphato complexes.
    Mishur RJ; Zheng C; Gilbert TM; Bose RN
    Inorg Chem; 2008 Sep; 47(18):7972-82. PubMed ID: 18693681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guanine nucleobase adducts formed by [Pt(di-(2-picolyl)amine)Cl]Cl: evidence that a tridentate ligand with only in-plane bulk can slow guanine base rotation.
    Andrepont C; Marzilli PA; Marzilli LG
    Inorg Chem; 2012 Nov; 51(21):11961-70. PubMed ID: 23094695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the reactions of platinum antitumor agents with biologic and nonbiologic sulfur-containing nucleophiles.
    Dedon PC; Borch RF
    Biochem Pharmacol; 1987 Jun; 36(12):1955-64. PubMed ID: 2954556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mixed unsymmetric oxadiazoline and/or imine platinum(II) complexes.
    Lasri J; Adília Januário Charmier M; da Silva MF; Pombeiro AJ
    Dalton Trans; 2007 Aug; (30):3259-66. PubMed ID: 17893771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of top-down and bottom-up Fourier transform ion cyclotron resonance mass spectrometry for mapping calmodulin sites modified by platinum anticancer drugs.
    Li H; Lin TY; Van Orden SL; Zhao Y; Barrow MP; Pizarro AM; Qi Y; Sadler PJ; O'Connor PB
    Anal Chem; 2011 Dec; 83(24):9507-15. PubMed ID: 22032417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure, solution chemistry, antiproliferative actions and protein binding properties of non-conventional platinum(II) compounds with sulfur and phosphorus donors.
    Mügge C; Rothenburger C; Beyer A; Görls H; Gabbiani C; Casini A; Michelucci E; Landini I; Nobili S; Mini E; Messori L; Weigand W
    Dalton Trans; 2011 Mar; 40(9):2006-16. PubMed ID: 21212880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetics and mechanism for reduction of the anticancer prodrug trans,trans,trans-[PtCl2(OH)2(c-C6H11NH2)(NH3)] (JM335) by thiols.
    Lemma K; Shi T; Elding LI
    Inorg Chem; 2000 Apr; 39(8):1728-34. PubMed ID: 12526561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteins as possible targets for cytotoxic trans-platinum(II) complexes with aliphatic amine ligands: Further exceptions to the DNA paradigm.
    Cubo L; Groessl M; Dyson PJ; Quiroga AG; Navarro-Ranninger C; Casini A
    ChemMedChem; 2010 Aug; 5(8):1335-43. PubMed ID: 20564276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.